Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment

NCT05673759 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT05673759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment
Lead sponsor
Boston University
Phase
Observational
Overall status
Terminated
Start date
March 6, 2023
Completion date
May 1, 2025
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, mild, mild cognitive impairment